Your session is about to expire
← Back to Search
Web-based IVF Education for Patient Understanding (WebIVF Trial)
N/A
Waitlist Available
Led By Tannys DR Vause, MD
Research Sponsored by Ottawa Fertility Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subject >18 years of age
English speaking and reading
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing an online educational program for patients undergoing IVF treatment. It aims to see if the program can improve their understanding of IVF, reduce their stress, and make them more satisfied compared to traditional classroom teaching.
Who is the study for?
This trial is for adults over 18 who are English-speaking, can consent, have internet access, and are undergoing their first IVF cycle. It's not for those who've had previous IVF treatments or teaching sessions, or haven't completed a baseline knowledge questionnaire.
What is being tested?
The study compares an interactive web-based teaching tool with a traditional didactic lecture for educating IVF patients. Participants will be randomly assigned to one of the two methods and evaluated on knowledge gain, stress levels, and satisfaction during their treatment cycle.
What are the potential side effects?
Since this trial involves educational interventions rather than medical treatments, there aren't typical side effects like you'd expect from medication. However, participants may experience varying levels of stress or satisfaction with the different teaching methods.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am older than 18 years.
Select...
I can speak and read English.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Web-based Teaching GroupExperimental Treatment4 Interventions
Patients randomized to the intervention group will receive a unique login and password to a link on the Ottawa Fertility Centre website. This will allow them access to a secure site containing required teaching modules. They will then complete an interactive teaching tool that contains the same educational content as the traditional presentation. Patients will be able to access a module that is specific to their stimulation protocol. The teaching tool does not need to be completed all at one time. Once completed, the information can still be accessed as many times as required.
Group II: Control groupActive Control4 Interventions
Participants randomized to the control arm of the study will participate in a traditional didactic teaching session. This session will be carried out by the nurse educator. This session will be attended by up to 10 other couples that may or may not be participating in the study. The nurse educator administering the session will not know which couples are participating in the study. Slides shown and information conveyed will be the same as that provided to the web-based group, however all three stimulation protocols will be presented to the participants regardless of their actual treatment protocol.
Find a Location
Who is running the clinical trial?
Ottawa Fertility CentreLead Sponsor
4 Previous Clinical Trials
368 Total Patients Enrolled
Schering-PloughIndustry Sponsor
162 Previous Clinical Trials
41,480 Total Patients Enrolled
Mark Evans, MBAStudy DirectorOttawa Fertiilty Centre
Tannys DR Vause, MDPrincipal InvestigatorOttawa Fertility Centre, University of Ottawa
Jason K Min, MDStudy DirectorOttawa Fertility Centre, University of Ottawa
Media Library
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.